Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,871 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
Elbanna M, Shiue K, Edwards D, Cerra-Franco A, Agrawal N, Hinton J, Mereniuk T, Huang C, Ryan JL, Smith J, Aaron VD, Burney H, Zang Y, Holmes J, Langer M, Zellars R, Lautenschlaeger T. Elbanna M, et al. Among authors: edwards d. Clin Lung Cancer. 2021 May;22(3):e342-e359. doi: 10.1016/j.cllc.2020.05.024. Epub 2020 Jun 2. Clin Lung Cancer. 2021. PMID: 32736936 Free PMC article.
Predictors of Nodal and Metastatic Failure in Early Stage Non-small-cell Lung Cancer After Stereotactic Body Radiation Therapy.
Cerra-Franco A, Liu S, Azar M, Shiue K, Freije S, Hinton J, Deig CR, Edwards D, Estabrook NC 3rd, Ellsworth SG, Huang K, Diab K, Langer MP, Zellars R, Kong FM, Wan J, Lautenschlaeger T. Cerra-Franco A, et al. Among authors: edwards d. Clin Lung Cancer. 2019 May;20(3):186-193.e3. doi: 10.1016/j.cllc.2018.12.016. Epub 2018 Dec 29. Clin Lung Cancer. 2019. PMID: 30711394 Free PMC article.
Phase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Lung Cancer.
Edwards DM, Schonewolf CA, Rice JD, Schipper M, Haken RKT, Matuszak M, Balter J, Jarema D, Arenberg DA, Piert M, Qin A, Kalemkerian GP, Schneider BJ, Ramnath N, Chapman CH, Elliott DA, Lawrence TS, Hearn J, Hayman JA, Jolly S. Edwards DM, et al. Int J Radiat Oncol Biol Phys. 2024 Jul 4:S0360-3016(24)00749-1. doi: 10.1016/j.ijrobp.2024.06.018. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38971385
Follow-up for human papillomavirus-related oropharynx cancer concentrated on unequal symptom change (FOCUS): Prospective patient-reported outcome collection.
Edwards DM, Gharzai LA, Wang W, Mayo C, Suresh K, Schipper M, Evans JR, Malloy K, Chinn SB, Prince M, Spector M, Shuman A, Stucken C, Swiecicki PL, Worden F, Jarema J, Henderson C, Kovach A, Brenner C, Shah JL, Mierzwa ML, Casper K. Edwards DM, et al. Head Neck. 2024 Nov;46(11):2687-2698. doi: 10.1002/hed.27778. Epub 2024 Apr 29. Head Neck. 2024. PMID: 38680087
Cannabis Use in Patients Seen in an Academic Radiation Oncology Department.
Cousins MM, Mayo C, Devasia T, Dykstra M, Regan S, Miller S, Allen SG, Bryant AK, Morales-Rivera K, Herr DJ, Edwards DM, Takayesu J, Birer S, Egerer N, Evans J, Elliott D, Henderson C, Laucis AM, McFarlane M, Dragovic AF, Shah J, Hayman JA, Coughlin LN, Ilgen M, Jagsi R. Cousins MM, et al. Among authors: edwards dm. Pract Radiat Oncol. 2023 Mar-Apr;13(2):112-121. doi: 10.1016/j.prro.2022.11.002. Epub 2022 Nov 30. Pract Radiat Oncol. 2023. PMID: 36460181 Free PMC article.
Pan-Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare System.
Miller SR, Schipper M, Fritsche LG, Jiang R, Strohbehn G, Ötleş E, McMahon BH, Crivelli S, Zamora-Resendiz R, Ramnath N, Yoo S, Dai X, Sankar K, Edwards DM, Allen SG, Green MD, Bryant AK. Miller SR, et al. Among authors: edwards dm. Cancer Med. 2024 Nov;13(21):e70379. doi: 10.1002/cam4.70379. Cancer Med. 2024. PMID: 39508134 Free article.
The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial Therapies.
Blum K, Elman I, Han D, Hanna C, Baron D, Gupta A, Kazmi S, Khalsa J, Bagchi D, McLaughlin T, Badgaiyan RD, Modestino EJ, Edwards D, Dennen CA, Braverman ER, Bowirrat A, Sunder K, Murphy K, Jafari N, Zeine F, Carney PR, Gold MS, Lewandowski KU, Sharafshah A, Pollack AR, Thanos PK. Blum K, et al. Among authors: edwards d. Open J Immunol. 2024 Sep;14(3):60-86. doi: 10.4236/oji.2024.143006. Open J Immunol. 2024. PMID: 39507617 Free PMC article.
3,871 results